Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS): Study design and harmonization

Nenhuma Miniatura disponível
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
CRIVELLI, Lucia
CALANDRI, Ismael Luis
SALINAS, Rosa Maria
VELILLA, Lina Marcela
CARAMELLI, Paulo
LOPERA, Francisco
SEVLEVER, Gustavo Emilio
Citação
ALZHEIMERS & DEMENTIA, v.19, n.9, p.4046-4060, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
INTRODUCTION: Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS) is the first non-pharmacological multicenter randomized clinical trial (RCT) to prevent cognitive impairment in Latin America (LA). Our aim is to present the study design and discuss the strategies used for multicultural harmonization. METHODS: This 1-year RCT (working on a 1-year extension) investigates the feasibility of a multi-domain lifestyle intervention in LA and the efficacy of the intervention, primarily on cognitive function. An external harmonization process was carried out to follow the FINGER model, and an internal harmonization was performed to ensure this study was feasible and comparable across the 12 participating LA countries. RESULTS: Currently, 1549 participants have been screened, and 815 randomized. Participants are ethnically diverse (56% are Nestizo) and have high cardiovascular risk (39% have metabolic syndrome). DISCUSSION: LatAm-FINGERS overcame a significant challenge to combine the region's diversity into a multi-domain risk reduction intervention feasible across LA while preserving the original FINGER design.
Palavras-chave
Alzheimer's disease, cognitive impairment, dementia lifestyle, multidomain intervention, prevention, randomized controlled trial, World-Wide FINGERS
URI
https://observatorio.fm.usp.br/handle/OPI/58766
Referências
  1. Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
  2. Comision Economica para America Latina y el Caribe (CEPAL), LCPUB20193P CEPAL
  3. Crivelli L, 2022, ARCH CLIN NEUROPSYCH, V37, P553, DOI 10.1093/arclin/acab080
  4. Edwards Jerri D, 2017, Alzheimers Dement (N Y), V3, P603, DOI 10.1016/j.trci.2017.09.002
  5. FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
  6. Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208
  7. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  8. Kim H, 2019, FRONT NEUROINFORM, V13, DOI 10.3389/fninf.2019.00060
  9. Kivipelto M, 2020, ALZHEIMERS DEMENT, V16, P1078, DOI 10.1002/alz.12123
  10. Kivipelto M, 2013, ALZHEIMERS DEMENT, V9, P657, DOI 10.1016/j.jalz.2012.09.012
  11. Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6
  12. Mattap SM, 2022, BMJ GLOB HEALTH, V7, DOI 10.1136/bmjgh-2021-007409
  13. Matthews FE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11398
  14. MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457
  15. Mukadam N, 2019, LANCET GLOB HEALTH, V7, pE596, DOI 10.1016/S2214-109X(19)30074-9
  16. Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5
  17. Nichols E, 2022, LANCET PUBLIC HEALTH, V7, pE105, DOI 10.1016/S2468-2667(21)00249-8
  18. Ribeiro F, 2022, AGEING RES REV, V81, DOI 10.1016/j.arr.2022.101703
  19. Suemoto CK, 2023, ALZHEIMERS DEMENT, V19, P1849, DOI 10.1002/alz.12820
  20. Tabak RG, 2012, AM J PREV MED, V43, P337, DOI 10.1016/j.amepre.2012.05.024
  21. Toga AW, 2016, ALZHEIMERS DEMENT, V12, P49, DOI 10.1016/j.jalz.2015.06.1896
  22. Vergara RC, 2022, ALZH DEMENT-DADM, V14, DOI 10.1002/dad2.12273

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM